Strategic Expansion Senn Chemicals AG is actively expanding its peptide API portfolio, including GLP-1 based APIs, signaling growth opportunities for partners seeking innovative peptide therapeutics and scalable cGMP manufacturing capabilities.

Integration with Granules Recent news indicates Granules India acquired Senn, creating potential for enhanced collaboration, cross-sell of cGMP services, and access to a broader distribution channel for peptide-based APIs.

Peptide Expertise With a long-standing focus since 1963 on peptides and related intermediates, Senn offers end-to-end capabilities from discovery through commercial production, appealing to biotech firms needing reliable scale-up and regulatory-ready processes.

Swiss Reliability Headquartered near Zurich with a focused range of services (cGMP manufacturing, process development, analytical method development, regulatory services) positions Senn as a dependable Swiss-CDMO partner for high-quality, on-time delivery.

Diverse Market Reach Serving biotech, pharma, diagnostics, cosmeceuticals and veterinary segments worldwide, Senn presents cross-vertical upsell opportunities to customers seeking multiple product formats (peptides, amino acid derivatives, nucleotides, excipients) under one supplier.